Achyut Healthcare Ratios

Achyut Healthcare Ltd Ratios

The Achyut Healthcare Ltd Ratios page provides a complete fundamental analysis of Achyut Healthcare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Achyut Healthcare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Achyut Healthcare Ltd (NSE: , BSE: 543499) is currently trading at ₹5.14, with a market capitalization of ₹1.17B. As a major player in the Distribution services sector and Medical distributors industry, Achyut Healthcare Ltd remains a key stock for fundamental analysis using Achyut Healthcare Ltd Ratios.

Achyut Healthcare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Achyut Healthcare Ltd P/E ratio currently stands at 140.52, making it one of the most tracked metrics in Achyut Healthcare Ltd Ratios.

Historically, the Achyut Healthcare Ltd P/E ratio has shown strong fluctuations:

• 2024: 140.52
• 2023: 171.92
• 2022: 220.66
• 2021: 349.49
• 2020: 0

The decline in Achyut Healthcare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Achyut Healthcare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.45.

Historical P/B trend:

• 2024: 2.45
• 2023: 2.84
• 2022: 3.52
• 2021: 1.52

Achyut Healthcare Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Achyut Healthcare Ltd P/S ratio currently stands at 25.20, an important part of Achyut Healthcare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 25.20
• 2023: 14.06
• 2022: 20.10
• 2021: 3.87

The rising Achyut Healthcare Ltd P/S ratio indicates improved revenue valuation by investors.

Achyut Healthcare Ltd Price to Cash Flow Ratio (P/CF)

The Achyut Healthcare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Achyut Healthcare Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 258.43
• 2022: 337.73
• 2021: 0
• 2020: 0

The declining Achyut Healthcare Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Achyut Healthcare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Achyut Healthcare Ltd EV currently stands at ₹699.21M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 699.21M
• 2023: 653.98M
• 2022: 424.08M
• 2021: 82.91M

Achyut Healthcare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Achyut Healthcare Ltd EV/EBITDA ratio is currently 0, a key metric in Achyut Healthcare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 1710
• 2022: 0
• 2021: 0

Stable Achyut Healthcare Ltd EV/EBITDA indicates balanced valuation.

Achyut Healthcare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Achyut Healthcare Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Achyut Healthcare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Achyut Healthcare Ltd ROE currently stands at 1.77%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 1.77
• 2023: 2.22
• 2022: 1.96
• 2021: 0.87

Declining ROE indicates pressure on profitability.

Achyut Healthcare Ltd Ratios Analysis Summary

The Achyut Healthcare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Achyut Healthcare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Achyut Healthcare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.